Jeffrey H. Cooper
2012 - KaloBios Pharmaceuticals
In 2012, Jeffrey H. Cooper earned a total compensation of $1.5M as Chief Financial Officer at KaloBios Pharmaceuticals.
Compensation breakdown
| Option Awards | $1,330,635 |
|---|---|
| Salary | $134,556 |
| Total | $1,465,191 |
Cooper received $1.3M in option awards, accounting for 91% of the total pay in 2012.
Cooper also received $134.6K in salary.
Rankings
In 2012, Jeffrey H. Cooper's compensation ranked 4,649th out of 11,487 executives tracked by ExecPay. In other words, Cooper earned more than 59.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,649 out of 11,487 | 60th |
Division Manufacturing | 1,621 out of 4,253 | 62nd |
Major group Chemicals And Allied Products | 372 out of 1,198 | 69th |
Industry group Drugs | 234 out of 920 | 75th |
Industry Pharmaceutical Preparations | 182 out of 700 | 74th |
Source: SEC filing on April 29, 2013.
Cooper's colleagues
We found two more compensation records of executives who worked with Jeffrey H. Cooper at KaloBios Pharmaceuticals in 2012.